PlainRecalls
FDA Drug Moderate Class II Terminated

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

Reported: December 5, 2012 Initiated: November 5, 2012 #D-067-2013

Product Description

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

Reason for Recall

Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Details

Units Affected
8,381 bottles
Distribution
Nationwide
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54. Recalled by Boehringer Ingelheim Roxane Inc. Units affected: 8,381 bottles.
Why was this product recalled?
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Which agency issued this recall?
This recall was issued by the FDA Drug on December 5, 2012. Severity: Moderate. Recall number: D-067-2013.